Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extensive Investigation of the Hemostatic Profile in a Prospective Cohort of Patients Affected by COVID-19

NCT04595110 is registered in ClinicalTrials.gov with ANNA FALANGA as lead sponsor.

NCT NCT04595110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04595110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extensive Investigation of the Hemostatic Profile in a Prospective Cohort of Patients Affected by COVID-19
Lead sponsor
ANNA FALANGA
Phase
Observational
Overall status
Unknown status
Start date
March 25, 2020
Completion date
May 10, 2021
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, thrombosis